Patent ID: 8329692

Claim:
A compound selected from the group consisting of No. Name and/or structure “A1” 6-(1-Methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-ylethoxy)- pyrimidin-2-yl]benzyl}-2H-pyridazin-3-one, sulfate “A2” 6-(1-Methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-ylethoxy)- pyrimidin-2-yl]benzyl}-2H-pyridazin-3-one, mesylate “A3” 6-(1-Methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-ylethoxy)- pyrimidin-2-yl]benzyl}-2H-pyridazin-3-one, besylate “A4” 6-(1-Methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-ylethoxy)- pyrimidin-2-yl]benzyl}-2H-pyridazin-3-one, p-tosylate “A5” 6-(1-Methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-ylethoxy)- pyrimidin-2-yl]benzyl}-2H-pyridazin-3-one, fumarate “A6” 6-(1-Methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-ylethoxy)- pyrimidin-2-yl]benzyl}-2H-pyridazin-3-one, maleate “A7” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, hydrochloride monohydrate “A8” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, hydrobromide “A9” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, mesylate “A10” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, besylate “A11” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, malate “A12” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, fumarate “A13” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, maleate “A14” 3-(1-{3-[5-(1-Methylpiperidin-4-ylmethoxy)pyrimidin-2- yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, p-tosylate or a tautomers or stereoisomer thereof.